Skip to content

Satellos Bioscience Inc.

MSLE· NasdaqCore metricsCIK 1421642

Pharmaceutical preparations552 peers

Last sale
Nov 5, 2026 · -4.98%
Market cap
$97.24M
15.46M shares
Filings
56
—
—
—
-$24.87M
FY 2025N/M FY25 yoy
-$26.46M
FY 2025N/M FY25 yoy
-$23.60M
FY 2025derivedN/M FY25 yoy
-$1.70
FY 2025N/M FY25 yoy
$9.80M
FY 2025−75.5% FY25 yoy
$97.24M
—
—
3.5×
-24.27%
—

FY2025 figures · derived

Price

$6.2943.23%$4.79since Jan 29, 2026
Nov 5, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$18.43MFY 2025
$18.43M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$18,426,000reported
FY 20242024-12-31$14,359,000reported

Segments

Geography
Assets by Geography, FY2024 to FY2025FY2024Canada · FY2024 · $49.62MAustralia · FY2024 · $979.00KUSA · FY2024 · $145.00KFY2025Canada · FY2025 · $31.01MAustralia · FY2025 · $669.00KUSA · FY2025 · $207.00K
LineFY2025ShareChange
Canada$31.01M97%−37.5%
Australia$669.00K2.1%−31.7%
USA$207.00K0.6%+42.8%
Total$31.89M

From the 40-F filed Mar 27, 2026MSLE

Pharmaceutical preparations

Satellos Bioscience Inc. is the 291st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Satellos Bioscience Inc. · CIK 1421642 · Engraved from SEC EDGAR